3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Carboplatin
129
pembrolizumab
124
Cisplatin
114
Paclitaxel
102
Gemcitabine
85
Specimen Handling
80
Magnetic Resonance Spectroscopy
80
Docetaxel
70
Dexamethasone
59
Cyclophosphamide
59
Pemetrexed
55
Bevacizumab
54
durvalumab
53
Doxorubicin
52
Radiotherapy
49
Capecitabine
49
Radiation
47
Oxaliplatin
47
Fluorouracil
47
Rituximab
42
Leucovorin
42
Vincristine
41
Lenalidomide
40
Etoposide
38
Letrozole
36
atezolizumab
35
Nivolumab
35
Prednisone
31
Bortezomib
31
130-nm albumin-bound paclitaxel
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Oviposition
×
90 days
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled